NASDAQ
Enzon Pharmaceuticals, Inc. (ENZN) has a free cash flow growth of -3609.68% as of Friday, May 29, 2026. This represents a 3488.53% decrease compared to its 12-month average of -100.59%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.